Tolerogenic Versus Inflammatory Activity of Peripheral Blood Monocytes and Dendritic Cells Subpopulations in Systemic Lupus Erythematosus

Overview

Journal Clin Dev Immunol

Specialty Allergy & Immunology

Date 2012 Sep 13

PMID 22969819

Citations 12

Authors

Tiago Carvalheiro

Ana Rodrigues

Ana Lopes

Luis Ines

Isabel Velada

Andreia Ribeiro

Antonio Martinho

Jose A P Silva

Maria L Pais

Artur Paiva

Affiliations

Soon will be listed here.

Abstract

Abnormalities in monocytes and in peripheral blood dendritic cells (DC) subsets have been reported in systemic lupus erythematosus (SLE). We aim to clarify the tolerogenic or inflammatory role of these cells based on ICOSL or IFN-α and chemokine mRNA expression, respectively, after cell purification. The study included 18 SLE patients with active disease (ASLE), 25 with inactive disease (ISLE), and 30 healthy controls (HG). In purified plasmacytoid DC (pDC) was observed a lower ICOSL mRNA expression in ASLE and an increase in ISLE; similarly, a lower ICOSL mRNA expression in monocytes of ALSE patients was found. However, a higher ICOSL mRNA expression was observed in ASLE compared to HG in myeloid DCs. Interestingly, clinical parameters seem to be related with ICOSL mRNA expression. Regarding the inflammatory activity it was observed in purified monocytes and CD14(-/low) CD16(+) DCs an increase of CCL2, CXCL9, and CXCL10 mRNA expression in ASLE compared to HG. In myeloid DC no differences were observed regarding chemokines, and IFN-α mRNA expression. In pDC, a higher IFN-α mRNA expression was observed in ASLE. Deviations in ICOSL, chemokine, and IFN-α mRNA expression in peripheral blood monocytes and dendritic cells subpopulations in SLE appear to be related to disease activity.

Citing Articles

Characterization of Dendritic Cells and Myeloid-Derived Suppressor Cells Expressing Major Histocompatibility Complex Class II in Secondary Lymphoid Organs in Systemic Lupus Erythematosus-Prone Mice.

Uribe F, Gonzalez-Martinez F, Echeverria-Araya S, Sepulveda-Pontigo A, Chavez-Villacreses K, Diaz-Bozo A Int J Mol Sci. 2025; 25(24.

PMID: 39769367 PMC: 11676837. DOI: 10.3390/ijms252413604.

Targeting interferon-γ in hyperinflammation: opportunities and challenges.

De Benedetti F, Prencipe G, Bracaglia C, Marasco E, Grom A Nat Rev Rheumatol. 2021; 17(11):678-691.

PMID: 34611329 DOI: 10.1038/s41584-021-00694-z.

Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes.

van Leeuwen-Kerkhoff N, Westers T, Poddighe P, Povoleri G, Timms J, Kordasti S Haematologica. 2021; 107(3):655-667.

PMID: 33567812 PMC: 8883570. DOI: 10.3324/haematol.2020.268136.

DNA-Mediated Interferon Signature Induction by SLE Serum Occurs in Monocytes Through Two Pathways: A Mechanism to Inhibit Both Pathways.

Porat A, Giat E, Kowal C, He M, Son M, Latz E Front Immunol. 2019; 9:2824.

PMID: 30619247 PMC: 6297782. DOI: 10.3389/fimmu.2018.02824.

ARID3a gene profiles are strongly associated with human interferon alpha production.

Ratliff M, Garton J, Garman L, Barron M, Georgescu C, White K J Autoimmun. 2018; 96:158-167.

PMID: 30297159 PMC: 6497177. DOI: 10.1016/j.jaut.2018.09.013.

References

Dallera M, Cardarelli P, Preston B, Witte A, Davis Jr J . Type I interferon correlates with serological and clinical manifestations of SLE. Ann Rheum Dis. 2005; 64(12):1692-7. PMC: 1755300. DOI: 10.1136/ard.2004.033753. View

Vallin H, Blomberg S, Alm G, Cederblad B, Ronnblom L . Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol. 1999; 115(1):196-202. PMC: 1905199. DOI: 10.1046/j.1365-2249.1999.00772.x. View

Gerl V, Lischka A, Panne D, Grossmann P, Berthold R, Hoyer B . Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function. Ann Rheum Dis. 2009; 69(7):1370-7. DOI: 10.1136/ard.2009.111021. View

Seitz H, Matsushima G . Dendritic cells in systemic lupus erythematosus. Int Rev Immunol. 2010; 29(2):184-209. PMC: 2892226. DOI: 10.3109/08830181003602507. View

Her M, Kim D, Oh M, Jeong H, Choi I . Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus. Lupus. 2009; 18(6):501-7. DOI: 10.1177/0961203308099176. View

Blomberg S, Eloranta M, Magnusson M, Alm G, Ronnblom L . Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum. 2003; 48(9):2524-32. DOI: 10.1002/art.11225. View

Fitzgerald-Bocarsly P, Dai J, Singh S . Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 2008; 19(1):3-19. PMC: 2277216. DOI: 10.1016/j.cytogfr.2007.10.006. View

Alvarez D, Vollmann E, von Andrian U . Mechanisms and consequences of dendritic cell migration. Immunity. 2008; 29(3):325-42. PMC: 2818978. DOI: 10.1016/j.immuni.2008.08.006. View

Lourenco S, de Carvalho F, Boggio P, Sotto M, Vilela M, Rivitti E . Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. J Cutan Pathol. 2007; 34(7):558-64. DOI: 10.1111/j.1600-0560.2006.00652.x. View

10.

Cederblad B, Blomberg S, Vallin H, Perers A, Alm G, Ronnblom L . Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. J Autoimmun. 1998; 11(5):465-70. DOI: 10.1006/jaut.1998.0215. View

11.

Ding D, Mehta H, McCune W, Kaplan M . Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol. 2006; 177(9):5878-89. DOI: 10.4049/jimmunol.177.9.5878. View

12.

Ronnblom L, Alm G, Eloranta M . Type I interferon and lupus. Curr Opin Rheumatol. 2009; 21(5):471-7. DOI: 10.1097/BOR.0b013e32832e089e. View

13.

Fransen J, van der Vlag J, Ruben J, Adema G, Berden J, Hilbrands L . The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther. 2010; 12(2):207. PMC: 2888204. DOI: 10.1186/ar2966. View

14.

Gaipl U, Munoz L, Grossmayer G, Lauber K, Franz S, Sarter K . Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun. 2007; 28(2-3):114-21. DOI: 10.1016/j.jaut.2007.02.005. View

15.

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

16.

Baechler E, Batliwalla F, Karypis G, Gaffney P, Ortmann W, Espe K . Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A. 2003; 100(5):2610-5. PMC: 151388. DOI: 10.1073/pnas.0337679100. View

17.

Okamoto A, Fujio K, Okamura T, Yamamoto K . Regulatory T-cell-associated cytokines in systemic lupus erythematosus. J Biomed Biotechnol. 2012; 2011:463412. PMC: 3247013. DOI: 10.1155/2011/463412. View

18.

Herrmann M, Voll R, Zoller O, Hagenhofer M, Ponner B, Kalden J . Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998; 41(7):1241-50. DOI: 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H. View

19.

Almeida J, Bueno C, Alguero M, Sanchez M, de Santiago M, Escribano L . Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells. Clin Immunol. 2001; 100(3):325-38. DOI: 10.1006/clim.2001.5072. View

20.

Gilliet M, Cao W, Liu Y . Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 2008; 8(8):594-606. DOI: 10.1038/nri2358. View